Haplox Biotechnology Co.
Latest round
- Series D
Last raised
- Jul 2022
Total raised
- $32M
Investors
- 8
About Haplox Biotechnology Co.
, LTD is a biotechnology company that engages in genetic testing services. The company has a research and development team of more than 80 people. The company’s founder and CEO, Dr.D. in Biomedicine from the University of New Mexico. The company has established R&D centers in both Shenzhen and the USA. The company has applied for more than 10 national and international patents and 18 software copyrights. In July 2020, it launched the covid-19 anti-epidemic system HCOVIS. In March 2019, the company was accredited by the College of American Pathologists' Laboratory Accreditation Program. The company mainly provides genetic testing services, including tumor testing, genetic disease screening, and the detection of infectious diseases based on COVID-19. It uses liquid biopsy, gene sequencing, artificial intelligence and other technologies and data analysis methods to provide accurate genomics diagnosis solutions and full-process management solutions.05%. Its business services more than three hundred hospitals in more than thirty provinces in China.
Who invested in Haplox Biotechnology Co.
8 investors across 5 rounds
See all investors in Haplox Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Haplox Biotechnology Co.
Who invested in Haplox Biotechnology Co.?
Haplox Biotechnology Co. has 8 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Haplox Biotechnology Co. raised?
Haplox Biotechnology Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Haplox Biotechnology Co. last raise money?
Haplox Biotechnology Co.'s most recent round on record is a Series D, in Jul 2022.
What does Haplox Biotechnology Co. do?
, LTD is a biotechnology company that engages in genetic testing services.
Where is Haplox Biotechnology Co. headquartered?
Haplox Biotechnology Co. is headquartered in Shenzhen, China.
Which VCs invest in companies like Haplox Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Haplox Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Haplox Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.